Head-To-Head Contrast: Aeterna Zentaris (NASDAQ:AEZS) versus Nexien BioPharma (OTCMKTS:NXEN)
Risk & Volatility Aeterna Zentaris has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Nexien BioPharma has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Profitability This table compares Aeterna Zentaris and Nexien BioPharma’s net margins, […]
Risk & Volatility Aeterna Zentaris has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Nexien BioPharma has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Profitability This table compares Aeterna Zentaris and Nexien BioPharma’s net margins, […]
